KRFK, a peptide derived from TSP-1, can activate TGF-beta. KRFK promotes TGF-beta-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK can be used for chronic ocular surface inflammatory disorders reseach[1].
Molecular Weight:
577.72
CAS Number:
[162290-78-0]
Formula:
C27H47N9O5
Target:
TGF-beta Receptor
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
